The novel approach of the medication represents a exciting advance in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets multiple pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide181224.canariblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56972903